News
The US Food and Drug Administration (FDA) has approved dupilumab (Dupixent) as the first targeted therapy for bullous ...
MedPage Today on MSN10hOpinion
'5 Years, 10 Years at Most, I'm Going to Retire': What We Heard This Week"It's not just taking something away, but really doing a careful assessment of how that medication works within that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback